Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Colli-Pee postal kits for home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Latest news

Does volume matter? Impact of collection volumes on detection of biomarkers and HPV DNA in first-void urine

It is well-established that Human Papillomavirus (HPV), the primary cause of cervical cancer can be detected in first-void urine. The study by Laura Téblick (University of Antwerp, Belgium) investigated whether different first-void urine volumes collected with Colli-Pee affects the detection of...

Latest blogpost

DNA methylation-based biomarkers have shown potential in disease detection and monitoring . This blog highlights areas in which DNA methylation could support cancer research and examples of biomarkers that are being investigated for various cancer types. Abnormal DNA methylation is common in cancer...

Upcoming event

STI & HIV world congress

Novosanis' team members will be attending the virtual STI & HIV world congress from July 14-17. They are looking forward to answer all your questions regarding Novosanis' home-based urine sampling solutions for STIs